Atlas Trials

Study of Octanorm Subcutaneous IG in Patients With PID

Clinical trial NCT01888484 · COMPLETED

Trial details

NCT number
NCT01888484
Sponsor
Octapharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Immune Deficiency Disorder
Start date
2014-03-01
Primary completion
2020-06-09
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.